Why the study?
Several types of antiarrhythmic drugs are known to induce QT prolongation and torsades de pointes.
Does isoproterenol infusion resolve bepridil-induced intraoperative torsades de pointes in a patient with atrial fibrillation?
Does isoproterenol infusion resolve bepridil-induced intraoperative torsades de pointes in a patient with atrial fibrillation?
Isoproterenol infusion can successfully treat bepridil-induced intraoperative torsades de pointes by increasing heart rate and counteracting bradycardia-induced QT prolongation.
May support isoproterenol for bepridil-induced intraoperative torsades; single case leaves open need for prospective validation.
BACKGROUND: Several types of antiarrhythmic drugs are known to induce QT prolongation and torsades de pointes. CASE PRESENTATION: An 84-year-old man was scheduled for open gastrectomy for residual cancer. He had been prescribed bepridil for atrial fibrillation that converted to sinus rhythm with prolonged QT interval in the operating room. After the surgery was initiated under general and epidural anesthesia, the patient's heart rate decreased to 50/min and multifocal premature ventricular contractions appeared, followed by several episodes of torsades de pointes, each lasting for 5 to 15 s. Infusion of isoproterenol was started (0.01 μg/kg/min), and the heart rate was maintained at around 80/min. Premature ventricular contractions disappeared, and torsades de pointes did not recur during the surgery. The operation was completed uneventfully. The serum bepridil concentration was found to be extremely high postoperatively. CONCLUSIONS: Bepridil-induced intraoperative episodes of torsades de pointes were successfully treated by increasing the heart rate with isoproterenol.
No takes yet. Share an insight, caveat, or question.
Shimano et al. (2021) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: